DNA damage. Cellular repair. Protein degradation. Oxidative stress. Inflammation. In longevity dermatology and the skincare marketing built on top of it, these five ideas are presented as the "pillars" of skin aging, and almost every serum, supplement, and clinic menu is pitched as targeting one or more of them. Patients arrive at the counter having absorbed the vocabulary. The useful questions for a pharmacist are the unglamorous ones: what does each term actually mean, do they all matter equally, and is any of them something you can diagnose and treat?

The short answer to the last one is no. None of the five is a disease state. They are biological mechanisms: processes that sit underneath many different diagnoses, and underneath normal aging too. That distinction shapes how a pharmacist should counsel, so it's worth getting precise.

What Each One Actually Means

1. DNA damage

Ultraviolet radiation chemically alters skin cell DNA, producing lesions such as cyclobutane pyrimidine dimers, and reactive oxygen species add oxidative lesions on top. Cells repair most of this damage through nucleotide excision repair; what slips through becomes mutation. This is the best-documented mechanism on the list, because the endpoint is hard and countable: actinic keratoses, basal and squamous cell carcinoma, and melanoma. The clearest proof that repair matters is xeroderma pigmentosum, where inherited defects in that repair machinery cause skin cancer in childhood. For everyone else, the intervention with the strongest evidence is still not a repair serum. It is not accumulating the damage in the first place: sun avoidance and broad-spectrum sunscreen.

2. Cellular repair

This is the vaguest of the five, and the most overused on labels. "Repair" can mean DNA repair, wound healing, barrier restoration, collagen synthesis, autophagy (the cell's recycling process), or clearance of senescent cells, which are quite different things. Real, evidence-backed examples exist for several of them: retinoids stimulate collagen synthesis, ceramides and niacinamide support the barrier, and wound-healing biology underlies post-procedure care. Newer candidates, such as topical estrogens and rapamycin, act on repair and senescence pathways but have far thinner skin-specific data. When a product claims "cellular repair," the productive follow-up question is: which repair process, and what was measured?

3. Protein degradation

In skin, this mostly means the breakdown of collagen and elastin. UV exposure activates the AP-1 transcription factor, which raises matrix metalloproteinases (MMP-1 in particular) that cleave dermal collagen, while glycation crosslinks the proteins that remain and stiffens the matrix. Over decades this produces the visible features of photoaging: wrinkling, laxity, and solar elastosis. A broader decline in the cell's ability to maintain properly folded proteins (proteostasis) is part of the longevity framing. The best-supported interventions are, again, photoprotection and topical retinoids, which counter MMP induction and boost new collagen.

4. Oxidative stress

UV, pollution, and normal metabolism generate reactive oxygen species faster than antioxidant defenses can neutralize them. Oxidative stress is mechanistically central: it feeds DNA damage, drives MMP expression, and amplifies inflammation. It has also been implicated in specific conditions, including vitiligo and melasma. Topical antioxidants such as vitamin C and vitamin E (especially combined with ferulic acid) are supported as photoprotective adjuncts. The honest summary is that they add to sunscreen rather than replace it, and that taking antioxidants orally has weaker evidence for visible skin outcomes than the marketing implies.

5. Inflammation

This one is unusual because it appears twice. Acute and chronic inflammatory skin diseases such as psoriasis, atopic dermatitis, and rosacea are real, diagnosable conditions with established treatments. The longevity usage means something different: "inflammaging," a low-grade, subclinical inflammatory state associated with aging tissue and senescent cells that secrete inflammatory mediators. The first meaning is clinical. The second is a research concept whose measurement and treatment in otherwise healthy skin are still being worked out. Patients rarely distinguish between them, and a pharmacist can.

Disease States, or Problems?

A useful way to sort this is with three tiers:

  • Disease state: a diagnosable condition with criteria, a typical course, and established treatments (psoriasis, actinic keratosis, melasma).
  • Mechanism: a biological process that contributes to one or more disease states (all five items here).
  • Patient concern: how the patient describes the problem, often in the vocabulary of marketing ("I want to repair my skin," "I need antioxidants").

All five pillars are mechanisms. Each connects to real disease states, but none is itself one:

  • DNA damage connects to actinic keratosis, non-melanoma skin cancer, melanoma, and xeroderma pigmentosum.
  • Cellular repair connects to wound healing, chronic ulcers, and recovery after procedures or injury.
  • Protein degradation connects to photoaging and solar elastosis.
  • Oxidative stress is implicated in photoaging, vitiligo, and melasma, among others.
  • Inflammation connects to psoriasis, atopic dermatitis, rosacea, acne, and many more, plus the subclinical "inflammaging" concept.

This is why these five don't belong in a disease-state database as entries of their own. The conditions they contribute to do.

Are They Equally Important?

Not in clinical terms, and not as five independent problems either. Roughly:

  • Most clinically consequential: DNA damage (it ends in cancer) and inflammation in its disease form (it drives the largest treatable burden in dermatology).
  • Most visible to patients: protein degradation, because collagen loss and elastosis are what people see in the mirror.
  • Mechanistically central, interventionally modest: oxidative stress, where the biology is solid but topical antioxidant evidence is mostly adjunctive.
  • Least well-defined: cellular repair, a catch-all whose usefulness depends entirely on which process is meant.

The bigger point is that the pillars are interdependent. A single UV exposure damages DNA, generates oxidative stress, switches on MMPs, triggers inflammation, and demands repair, all at once. That is why the single most effective intervention against all five is the least exciting one: consistent sun protection. A five-pillar framework is a good way to explain aging. It is not five separate problems requiring five separate products.

What Pharmacists Actually See

Patients almost never ask about a mechanism. They ask about a product, an ingredient, or something they saw online. In practice, these five ideas surface in the pharmacy as:

  • Questions about OTC antioxidant serums, peptides, and "anti-aging" regimens, and whether they're worth the cost.
  • Prescriptions and refill questions for tretinoin and hydroquinone, often with confusion about safety, duration, and the fact that hydroquinone has been prescription-only in the U.S. since 2020.
  • Compounded prescriptions that originate from longevity clinics or telehealth services, such as topical rapamycin or estriol, often with little context about the evidence behind them.
  • Supplement questions involving NAD+ precursors, collagen peptides, and polyphenols.
  • Consequences of layering too many actives: irritation, barrier damage, and the need to pull back to basics.
  • Photosensitizing medications, an easily overlooked link between a patient's drug list and their DNA-damage risk.

How Patients Bring It Up

The language is rarely clinical. Common openers include "something to boost collagen," "I want to repair sun damage," "a serum that actually works at the cellular level," and "I saw rapamycin cream on Instagram." Some patients come with lab or biomarker results from a longevity clinic or a consumer test; others have simply read an ingredient label. Pharmacists are well placed to translate, and a few questions help:

  • What outcome are you hoping for: fewer wrinkles, less pigmentation, a lower cancer risk, or something else?
  • What does your daily sun protection actually look like?
  • What are you already using, and has anything been irritating?
  • Is this product something a clinician prescribed, or something you found yourself? Are you pregnant, nursing, or managing a hormone-sensitive condition?

Three Ingredients Worth Knowing

Three ingredients that come up in this conversation have been added to the Society's Ingredient Database, each with an evidence rating:

  • Estriol is a weak estrogen that has been studied topically in postmenopausal skin, with small trials (many with estradiol rather than estriol) suggesting gains in collagen, thickness, and elasticity. It is a hormone available only by prescription and compounding, so systemic exposure and patient-specific risk matter. Emerging.
  • Hydroquinone remains the gold standard for hyperpigmentation such as melasma. Since the September 2020 CARES Act reform, OTC products are no longer lawfully marketed in the U.S., and it is available by prescription (Tri-Luma or compounded). Use in limited cycles under supervision limits the risk of irritation and exogenous ochronosis. Established.
  • Rapamycin (sirolimus) is an mTOR inhibitor. Topical sirolimus is FDA-approved only for facial angiofibromas in tuberous sclerosis. A small exploratory randomized trial in older adults found reduced p16INK4A senescence markers and modest clinical improvement, which is encouraging but early. Longevity-clinic use relies on compounded, unapproved preparations. Emerging.

Notice that these don't map neatly onto individual pillars. Hydroquinone, for example, works by inhibiting tyrosinase, not by treating oxidative stress. That is the same lesson in miniature: the pillar framework is a story about aging, not a prescribing guide.

The Takeaway

These five mechanisms are real, and understanding them helps explain why sun protection, retinoids, and a short list of well-studied actives work. But none is a disease state, they are not equally important, and they are not independent. The most useful thing a pharmacist can do is separate three things the marketing blurs: the mechanism a product claims to target, the evidence that it works in human skin, and what the patient actually wants to change.

This article is for educational purposes and does not constitute medical or pharmaceutical advice. Consult a qualified healthcare provider or dermatologist for personalized recommendations.

Sources:
Chung CL et al., "Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial," GeroScience, 2019.
"Topical estrogen therapy for aging skin: Current evidence and clinical considerations," ScienceDirect, 2025.
"CARES Act legislation halting sales of OTC hydroquinone is now in effect," Medical Esthetics.
Related: Skinspan: What Systemic Biomarkers Reveal About How Skin Actually Ages.